Stay updated with breaking news from Global Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Blood-based test for comprehensive genomic profiling of solid cancers meets requirements under stricter EU In Vitro Diagnostic Regulation IVDR certification from TÜV SÜD enables broader adoption
– Data from pivotal Phase III STARS study in short bowel syndrome with intestinal failure accepted as late-breaker oral presentation on May 21 at 10:30 am ET – – Findings from the STARS...
01.05.2024 - Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that the company will present new data from studies evaluating apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF), a ... Seite 1
AMLX DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Alerts ...
AMLX 3-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, ...